Free Trial

Pfizer Headlines Pressure Core FI

BOND SUMMARY

Headlines noting that Pfizer's Covid-19 vaccine could receive regulatory review as soon as in Oct triggered some light risk-on flows, prompting T-Notes to post a leg lower. The contract last sits -0-01 at 139-17, off the reaction low of 139-13+. Yields generally trade slightly lower, curve runs marginally flatter. Eurodollar futures last seen unch. to -1.0 tick through the reds.

  • Despite having a look above overnight highs in early trade, JGB futures have eased off on the back of aforementioned Pfizer news. The contract last trades at 151.93, 1 tick above settlement. Yield curve runs flatter, with 7s outperforming & 3s lagging. Japanese CPI data provided no notable deviations from expectations, while the BoJ's 1-3, 5-10 & 25+ Year Rinban ops saw all purchase sizes unchanged.
  • In Oz, YM trades -0.5, with XM unch. and off highs owing to the Pfizer headlines. Cash ACGB curve has flattened marginally, with yields sitting +0.4bp to -0.4bp. Bills last trade -1 to +1 tick through the reds. The space has shown little reaction to a decent ACGB Nov '24 auction and local data. Preliminary readings of CBA PMIs showed that the services sector has moved into contraction, while flash retail sales rose 3.3% in July.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.